홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Oxprenolol

HCID 4631
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
6452-71-7
표준 SMILES
C=CCOc1ccccc1OCC(O)CNC(C)C
InChIKey
CEMAWMOMDPGJMB-UHFFFAOYSA-N
분자식
C15H23NO3
평균 분자량
265.35 g/mol
단동위원소 질량
265.1677936

개요

1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)-2-propanol is an aromatic ether.

이름 및 식별자

우선 이름
Oxprenolol
IUPAC
1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol
영어명
oxprenolol
분자식
C15H23NO3
분자량
265.35

이름 및 동의어

oxprenolol6452-71-7CoretalOxprenololum519MXN9YZRDTXSID10438352-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-2-Propanol, 1-[(1-methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-{2-hydroxy-3-[2-(prop-2-en-1-yloxy)phenoxy]propyl}(propan-2-yl)amineoxprenololo(2-hydroxy-3-(2-(prop-2-en-1-yloxy)phenoxy)propyl)(propan-2-yl)amineTrasicor, Slow
이름 더 보기
TevacorOxenalolAids001596Aids-001596Oxprenolol-d7oxprenolol USP/EP/BPCoretal (hydrochloride)1-(2-allyloxyphenoxy)-3-isopropylaminopropan-2-ol
RefChem:857811DTXCID9023835C07AA02229-257-9245-359-6dl-Oxprenolol(+-)-OxprenololOsprenololo [DCIT]

데이터베이스 식별자

CAS
6452-71-7
PubChem CID
4631
DTXSID
DTXSID1043835
ChEMBL
CHEMBL546
ChEBI
CHEBI:91704
UNII
519MXN9YZR
EC Number
229-257-9
Nikkaji
J318.375K、J8.410G

물성

구조 계산 물성

XLogP
2.1
극성 표면적
50.7 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
4
회전 가능 결합 수
9
무거운 원자 수
19
형식 전하
0
복잡도
246

실험 및 물리화학적 성질

Chemical ClassesOther Uses -> Pharmaceuticals
Drugs · 2건

Pharmaceuticals

Pharmaceuticals -> Antihypertensives

LogP · 2건

2.10

2.25

Solubility6.80e-01 g/L
Human DrugsPharmaceuticals
Physical DescriptionSolid
Dissociation Constants9.57
Collision Cross Section161.7 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

물리화학적 성질

녹는점
78 · 78-80°
끓는 점
408.57 °C · 408.57°C (rough estimate)
밀도
1.0479 · 1.0479 (rough estimate)
굴절률
1.5 · 1.5000 (estimate)
용해도
디클로로메탄(약간 용해됨), 메탄올(약간 용해됨)
물리적 상태
고체
산도 계수 (pKa)
13.89 · 13.89±0.20(Predicted)
색상
흰색에서 황백색까지
안정성
Stable under recommended storage conditions., Stable Under Recommended Storage C

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P262, P264, P270, P271, P280, P301+P316, P302+P352, P304+P340, P316, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

유해성 정보

Regulatory Information2-Propanol, 1-(1-methylethyl)amino-3-2-(2-propenyloxy)phenoxy-: Does not have an individual approval but may be used under an appropriate group standard
Hazards SummaryAllergic contact dermatitis reported in a pharmaceutical worker; [Kanerva, p. 1822] See Propranolol.
Hazard Classes and CategoriesAcute Tox. 3 (100%)

독성 정보

Adverse EffectsSkin Sensitizer - An agent that can induce an allergic reaction in the skin.

안전 데이터

신호 어
Danger
유해·위험 문구
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드 H301

화학 및 산업

약리 정보

ATC Code · 2건

C - Cardiovascular system

QC - Cardiovascular system

Pharmacodynamics · 1건

Oxprenolol is a non-selective beta blocker with some intrinsic sympathomimetic activity. Oxprenolol is a lipophilic molecule and hence, it is able to cross the blood-brain barrier. As such, it is associated with a higher incidence of CNS-related side effects than hydrophilic ligands such as atenolol, sotalol and nadolol. Oxprenolol is an potent beta-blocker and should not be administered to asthmatics because it can cause irreversible airway failure and inflammation.

Mechanism of Action · 1건

Like other beta-adrenergic antagonists, oxprenolol competes with adrenergic neurotransmitters such as catecholamines for binding at sympathetic receptor sites. Like propranolol and timolol, oxprenolol binds at beta(1)-adrenergic receptors in the heart and vascular smooth muscle, inhibiting the effects of the catecholamines epinephrine and norepinephrine and decreasing heart rate, cardiac output, and systolic and diastolic blood pressure. It also blocks beta-2 adrenergic receptors located in bronchiole smooth muscle, causing vasoconstriction. By binding beta-2 receptors in the juxtaglomerular apparatus, oxprenolol inhibits the production of renin, thereby inhibiting angiotensin II and aldosterone production. Oxprenolol therefore inhibits the vasoconstriction and water retention due to angiotensin II and aldosterone, respectively.

Biological Half-Life1-2 hours
Metabolism/Metabolites · 2건

Hepatic.

Oxoprenolol has known human metabolites that include Oxprenolol glucuronide.

MeSH Pharmacological Classification · 6건

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Drugs used to cause dilation of the blood vessels.

Absorption, Distribution and ExcretionOral bioavailability is 20-70%.
Cellular LocationsMembrane
Metabolite PathwaysOxprenolol Action Pathway

용도 및 제조

Uses · 2건

Used as a beta-blocking agent; [Kanerva, p. 1822]

Use (kg; approx.) in Germany (2009): >50

Use ClassificationPharmaceuticals

응용 분야

개요Oxprenolol induced contact dermatitis in a worker at a pharmaceutical plant, in the division for drug synthesis. Epichlorhydrin was also used for the production of both propranolol and oxprenolol.

용도Oxprenolol is a free base of Oxprenolol Hydrochloride(O870500) which is a β-Adrenergic blocker. Antihypertensive, antianginal, antiarrhythmic.

상·하류 제품 정보

상류 원료

이소프로필아민에피클로로하이드린

관련 반응

1건
반응 기록 만들기
HRID 328893 반응식
HRID 328893생성물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트